ATE308993T1 - Substratmaterialien mit gebundenen cytokin- stimulierenden polysacchariden oder bakteriellen nukleinsäuren - Google Patents

Substratmaterialien mit gebundenen cytokin- stimulierenden polysacchariden oder bakteriellen nukleinsäuren

Info

Publication number
ATE308993T1
ATE308993T1 AT98921925T AT98921925T ATE308993T1 AT E308993 T1 ATE308993 T1 AT E308993T1 AT 98921925 T AT98921925 T AT 98921925T AT 98921925 T AT98921925 T AT 98921925T AT E308993 T1 ATE308993 T1 AT E308993T1
Authority
AT
Austria
Prior art keywords
nucleic acids
stimulating
bacterial nucleic
substrate materials
polysaccharides
Prior art date
Application number
AT98921925T
Other languages
English (en)
Inventor
Terje Espevik
Gudmund Skjak-Braek
Original Assignee
Fmc Biopolymer As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Biopolymer As filed Critical Fmc Biopolymer As
Application granted granted Critical
Publication of ATE308993T1 publication Critical patent/ATE308993T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087Polysaccharides; Lipopolysaccharides [LPS]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT98921925T 1997-05-16 1998-05-13 Substratmaterialien mit gebundenen cytokin- stimulierenden polysacchariden oder bakteriellen nukleinsäuren ATE308993T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9710010A GB2325233B (en) 1997-05-16 1997-05-16 Substrates having bound polysaccharides and bacterial nucleic acids
PCT/NO1998/000146 WO1998051342A1 (en) 1997-05-16 1998-05-13 Substrates materials with bound cytokine-stimulating polysaccharides or bacterial nucleic acids

Publications (1)

Publication Number Publication Date
ATE308993T1 true ATE308993T1 (de) 2005-11-15

Family

ID=10812458

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98921925T ATE308993T1 (de) 1997-05-16 1998-05-13 Substratmaterialien mit gebundenen cytokin- stimulierenden polysacchariden oder bakteriellen nukleinsäuren

Country Status (7)

Country Link
EP (1) EP1011722B1 (de)
JP (1) JP2002508788A (de)
AT (1) ATE308993T1 (de)
DE (1) DE69832290T2 (de)
DK (1) DK1011722T3 (de)
GB (1) GB2325233B (de)
WO (1) WO1998051342A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100501584B1 (ko) 2000-02-03 2005-07-18 (주)케이비피 저분자 폴리만유로네이트의 제조방법, 혈청지질개선제로서의 이의 신규 용도 및 이를 함유하는 기능성식품 및 건강 보조 식품
KR100456681B1 (ko) 2002-05-22 2004-11-10 주식회사 대웅 박테리아의 염색체 dna 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물
JPWO2007069468A1 (ja) * 2005-12-14 2009-05-21 国立大学法人 長崎大学 サイトカイン分泌促進剤
KR101690631B1 (ko) 2007-11-27 2017-01-09 알지파마 아이피알 에이에스 바이오필름 퇴치에 있어서의 알기네이트 올리고머의 용도
BRPI1011248A2 (pt) 2009-06-03 2016-03-22 Algipharma As métodos in vitro ou ex vivo de superação de resitência a pelo menos um antibiótico, para combate de contaminação de um sítio e melhora da eficácia de um antibiótico de macrolídeo para inibir o crescimento de bactéria mdr gram negativa, uso de um oligômero de alginato e produto

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
CA1083508A (fr) * 1975-11-13 1980-08-12 Jacques Grange Supports porteurs de chaines laterales, procedes d'obtention de ces supports, procedes de fixation de composes organiques comportant un residu glucidique sur lesdits supports, produits et reactifs resultant de ladite fixation chimique
US4701521A (en) * 1978-07-17 1987-10-20 The Trustees Of Boston University Method of effecting cellular uptake of molecules
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
US5171738A (en) * 1982-10-04 1992-12-15 Toray Industries, Inc. Method of treating malignant tumors
US4650675A (en) * 1983-08-18 1987-03-17 The Children's Medical Center Corporation Oligonucleotide conjugates
SE466289B (sv) * 1984-09-19 1992-01-27 James Hoffman Makrofagstimulerande komposition jaemte foerfarande foer dess framstaellning
ATE41159T1 (de) * 1985-08-29 1989-03-15 Berol Kemi Ab Traeger mit einer immobilisierten biologischaktiven substanz, verfahren zur herstellung und seine verwendung.
US4870158A (en) * 1987-01-05 1989-09-26 University Of Pittsburgh Of The Commonwealth System Of Higher Education Polymyxin lipopolysaccharide antigen and associated method
EP0491829B1 (de) * 1989-09-08 1997-06-04 Alpha Beta Technology, Inc. Zusammensetzung zur Stimulierung des Immunsystems
US5169840A (en) * 1991-03-27 1992-12-08 Nobipols Forskningsstiftelse Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation
US5166137A (en) * 1991-03-27 1992-11-24 Nobipols Forskningsstiftelse Guluronic acid polymers and use of same for inhibition of cytokine production
US5457187A (en) * 1993-12-08 1995-10-10 Board Of Regents University Of Nebraska Oligonucleotides containing 5-fluorouracil
KR19990028383A (ko) * 1995-06-26 1999-04-15 지 더블유 페이스 신규한 보조제 조성물 및 이것을 함유한 백신 제제

Also Published As

Publication number Publication date
GB2325233A (en) 1998-11-18
GB2325233B (en) 2001-07-18
DE69832290T2 (de) 2006-07-13
EP1011722B1 (de) 2005-11-09
DE69832290D1 (de) 2005-12-15
DK1011722T3 (da) 2006-03-27
EP1011722A1 (de) 2000-06-28
GB9710010D0 (en) 1997-07-09
WO1998051342A1 (en) 1998-11-19
JP2002508788A (ja) 2002-03-19

Similar Documents

Publication Publication Date Title
CA2003455A1 (en) Immunotherapy involving cd28 stimulation
SE9701691D0 (sv) Förfarande för framställning av dekorativt laminat och användning därav
DE68908456D1 (de) Matrix zur wirkstoffabgabe.
IT1188212B (it) Sistema per il rilascio a velocita' controllata di sostanze attive
BR9916266A (pt) Artigo abrasivo aglutinado usando-se um aglutinante hìbrido
DK0662000T3 (da) Antigen-bærende mikropartikler og deres anvendelse til at inducere humorale eller cellulære responser
ATE47155T1 (de) Monoklonaler antikoerper.
EP0320146A3 (de) Produkt zum Polieren von Glas
ATE308993T1 (de) Substratmaterialien mit gebundenen cytokin- stimulierenden polysacchariden oder bakteriellen nukleinsäuren
DE59410132D1 (de) Humanes zirkulierendes cytokin cc-1
EP1106189A3 (de) Lichthärtender Gewebeklebstoff
DE68923680D1 (de) Oberflächenbehandlung zur Verbesserung des Haftvermögens von Anstrichen an Polydicyclopentadienen.
IT8885509A0 (it) Procedimento per il rinforzo strutturale di manufatti fragili di marmo o pietra in genere eprodotto cosi' ottenuto.
PT1161353E (pt) Superficies resina transparente nas quais e embutido marmore ou outras pedras
NO934106L (no) Liposome polysakkarid-vaksiner
AU4909399A (en) Disinfecting antibacterial wood particle laminate
RU93000165A (ru) Декоративный элемент
IT1269385B (it) Impianto di stoccaggio di prodotti, in particolare di piastrelle ceramiche e simili
ID24239A (id) Metode dan aparatus untuk mengendalikan batang kayu yang telah dibuang kulit kayunya
ITBO970193A0 (it) Impilatore di prodotti appiattiti, in particolare piastrelle ceramiche
FR2672611B1 (fr) Produits photoluminescents notamment de revetement de surfaces et ses applications.
DE3782885D1 (de) Klebstoffzusammensetzungen und laminate.
CN2277331Y (zh) 人造板斜粘式面板
IT1297753B1 (it) Sistema di caricamento pressa, per la formatura di piastrelle ceramiche ad imitazione di pietre naturali, quali marmi, graniti e/o
Basht et al. Effect of altitude and pH of soil on the collembolan populations in the ecosystem of Garhwal Himalayas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties